Human cytomegalovirus protects endothelial cells from apoptosis induced by growth factor withdrawal

Journal of Clinical Virology

Volumn 25, Issue SUPPL. 2, 2002, Pages 149-157

  Billstrom Schroeder, Marcella ^a,b   Christensen, Robert ^a,b   Worthen, G Scott ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Apoptosis; Cytomegalovirus; Endothelial cells; Growth factor withdrawal

Indexed keywords

CASPASE 3; CHEMOKINE RECEPTOR; GROWTH FACTOR; RANTES;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NICK END LABELING; PRIORITY JOURNAL; TIME; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0036702165     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6532(02)00090-2     Document Type: Article

References (19)

1. Albrecht T., Fons M., Boldogh I., AbuBake S., Deng C., Millinoff D. Metabolic and cellular effects of HCMV infection. Transplant. Proc. 23:1991;48-55.
2. Billstrom Schroeder M., Worthen G. Viral regulation of RANTES expression during HCMV infection of endothelial cells. J. Virol. 75:2001;3383-3390.
3. Billstrom M., Johnson G., Avdi N., Worthen G. Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection. J. Virol. 72:1998;5535-5544.
4. Cohen G. Caspases: the executioners of apoptosis. Biochem. J. 326:1997;1-16.
5. Foreman K., Wrone-Smith T., Boise L., Thompson C., Polverini P., Simonian P., Nunez G., Nickoloff B. Kaposi's sarcoma tumor cells preferentially express Bcl-xL. Am. J. Pathol. 149:1996;795-803.
6. Gimbrone M. Culture of vascular endothelium. Prog. Hemost. Thromb. 3:1976;1-28.
7. Goyal L. Cell death inhibition: keeping caspases in check. Cell. 104:2001;805-808.
8. Hengartner M. The biochemistry of apoptosis. Nature (London). 407:2000;770-776.
9. Herren B., Levkau B., Raines E., Ross R. Cleavage of β-Catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol. Biol. Cell. 9:1998;1589-1601.
10. Koedood M., Fichtel A., Meier P., Mitchell P. HCMV immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J. Virol. 69:1995;2194-2207.
11. Kovacs A., Weber M., Burns L., Jacob H., Vercellotti G. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am. J. Pathol. 149:1996;1531-1539.
12. Levkau B., Herren B., Koyama H., Ross R., Raines E. Caspase-mediated cleavage of focal adhesion kinase pp125FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J. Exp. Med. 187:1998;579-586.
13. Li P., Nijhawan D., Budihardjo I., Srinivasula S., Ahmad M., Alnemri E., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
14. Mostoufi-zadeh M., Driscoll S., Biano S., Kundsin R. Placental evidence of cytomegalovirus infection of the fetus and neonate. Arch. Pathol. Lab. Med. 108:1984;403-406.
15. Neote K., DiGregorio D., Mak J., Horuk R., Schall T. Molecular cloning, functional expression and signaling characteristics of a CC chemokine receptor. Cell. 72:1993;415-425.
16. Percivalle E., Revello M., Vago L., Morini F., Gerna G. Circulating endothelial giant cells permissive for HCMV are detected in disseminated HCMV infections with organ involvement. J. Clin. Invest. 92:1993;663-670.
17. VanderHeiden M., Chandel N., Schumacker P., Thompson C. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol. Cell. 3:1999;159-167.
18. Whitehead T., Kricka L., Carter T., Thorpe G. Analytical luminescence: its potential in the clinical laboratory. Clin. Chem. 25:1979;1531-1546.
19. Zhu H., Shen Y., Shenk T. HCMV IE1 and IE2 proteins block apoptosis. J. Virol. 69:1995;7960-7970.